Mathieu Cinier acquired extensive training in protein engineering and biotechnology. He has since joined Affilogic, and successfully led 50+ Nanofitin generation programs for a wide range of applications, several of them being currently developed as drug candidates in collaboration with international pharmaceutical partners. He also applied its protein engineering knowledge to expand the potential of the Nanofitin technology, before taking the position of Scientific Director in Jan. 2015.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)